Josephine G. M. Strijker

Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy

Judith Wienke, Lindy L. Visser, Waleed M. Kholosy et al. · Cancer Cell · 2024 · 101 citations · Full text

Life Sciences, Immunology, Oncology +17

Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch

Annelisa M. Cornel, Ester Dünnebach, Damon A. Hofman et al. · Journal for ImmunoTherapy of Cancer · 2022 · 40 citations · Full text

Medicine, Immunology, Oncology +17

Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastoma

Josephine G. M. Strijker, Guillem Pascual‐Pasto, Grant P. Grothusen et al. · European Journal of Cancer · 2025 · 17 citations · Full text

Medicine, Immunology, Oncology +17

αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I Expression

Josephine G. M. Strijker, Ronja Pscheid, Esther Drent et al. · Journal of Personalized Medicine · 2021 · 14 citations · Full text

Life Sciences, Immunology, Oncology +17

Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine

Karin P.S. Langenberg, Sander R. van Hooff, Bianca Koopmans et al. · European Journal of Cancer · 2025 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17